Affiliation:
1. Department of Economics, School of Liberal Arts Tulane University New Orleans Louisiana USA
2. Harris School of Public Policy University of Chicago Chicago Illinois USA
Abstract
AbstractPrescription opioid use among women of reproductive age and pregnant women is relatively common, and increased prescription opioid use is associated with a commensurate increase in opioid use disorder (OUD) among pregnant women and neonatal abstinence syndrome (NAS) among infants. In this article, we examine whether state opioid control policies affected prescription opioid use and, in turn, infant health and maternal behaviors. Results from our analysis suggest that reductions in prescription opioid use because of state prescription opioid control policies have improved infant health marginally at the population level with larger implied effects at the individual level.
Reference71 articles.
1. Opioid prescription claims among women of reproductive age—United States, 2008–2012;Ailes E.C.;MMWR. Morbidity and Mortality Weekly Report,2015
2. Childhood Circumstances and Adult Outcomes: Act II
3. ACOG Committee Opinion #313: The Importance of Preconception Care in the Continuum of Womenʼ Health Care
4. American College of Obstetricians and Gynecologists. (2017)ACOG statement on opioid use during pregnancy.
5. Arteaga Cabrales C.&Barone V.(2021)The opioid epidemic: causes and consequences. University of Toronto Department of Economics.